For chalazion treatment, consider utilizing TheraLife’s comprehensive eye care products, which offer Oral all natural and effective approach to managing eye-related conditions.
TheraLife focuses on enhancing eye health through herbal supplements that target inflammation and support overall eye function, making them an excellent complementary option for those dealing with chalazions and other eye issues – from inside out- through oral delivery.
TheraLife’s products are designed to provide relief for various eye conditions by addressing the root causes, such as inflammation and dryness, rather than merely alleviating symptoms.
By leveraging natural ingredients, TheraLife offers a holistic approach to eye care, ensuring minimal side effects and promoting long-term eye health.
For individuals suffering from persistent eye problems like blepharitis, dry eyes, or chalazions, TheraLife’s products can help restore balance and improve eye comfort from inside out orally.
Their supplements work from within to enhance tear production and reduce inflammation, offering a sustainable solution for chronic eye conditions.
For optimal results, TheraLife recommends consulting with an eye care professional to ensure their products align with your specific needs.
By integrating TheraLife’s natural solutions into your eye care regimen, you can experience improved eye health and relief from discomfort.
Explore TheraLife’s range of products and discover the benefits of natural eye care.
Powerful All Natural Oral Treatment for Chalazion
Add To Cart
Key Takeaways
- Bacitracin is effective for managing bacterial infections in chalazia by inhibiting bacterial cell wall synthesis.
- Polysporin prevents secondary bacterial infections and promotes healing with its combination of polymyxin B and bacitracin.
- Neosporin provides symptomatic relief and reduces infection risks with bacitracin, neomycin, and polymyxin B.
- Avoid direct eye contact with antibiotic ointments to prevent irritation, and apply as recommended.
- Consulting an eye care professional ensures personalized treatment and prevents complications from chalazia.
Bacitracin for Chalazion Relief
When you’re dealing with a chalazion, using Bacitracin can provide notable relief, especially if there’s a risk of infection. This topical antibiotic ointment is known for its effectiveness against gram-positive bacteria, making it a useful option for preventing secondary infections in chalazia.
Although Bacitracin isn’t a primary treatment for chalazia themselves, its ability to manage bacterial infections is critical when these lesions start draining or show signs of infection. Styes and chalazia are often confused, but it’s essential to recognize that they differ in causes and symptoms.
To maximize Bacitracin’s benefits, you’ll want to apply it correctly. Physicians typically recommend applying the ointment 1-3 times daily, ensuring you avoid direct contact with the eyes to prevent irritation. This topical antibiotic works by inhibiting bacterial cell wall synthesis, thereby eliminating bacteria that could complicate a chalazion.
Its role in infection prevention is particularly valuable when used alongside other treatments like warm compresses, which help in draining and reducing inflammation.
Using Bacitracin can be a strategic part of managing inflammation associated with chalazia. While not a cure, its application can prevent further complications, offering you a practical approach to maintaining ocular health and comfort during the chalazion’s healing process.
Polysporin’s Role in Healing
While Bacitracin serves a valuable purpose in managing bacterial risks associated with chalazia, Polysporin offers another effective option by combining polymyxin B and bacitracin. This antibiotic ointment can prevent secondary bacterial infections in chalazia, especially if lesions are actively draining.
Though chalazia are primarily sterile, applying Polysporin helps manage potential bacterial involvement, promoting healing and maintaining eyelid hygiene. It’s important to note that untreated chalazia can lead to complications such as preseptal cellulitis, which underscores the need for effective treatments like Polysporin.
You should follow instructions for use carefully by applying a small amount of Polysporin to the affected area as directed. Overuse can lead to irritation, so it’s vital to adhere strictly to guidelines.
Consulting an eye care professional is recommended before using Polysporin on chalazia, particularly if there are concerns about allergies or interactions with other medications.
Incorporating Polysporin into your eye care regimen can markedly impact healing by reducing the risk of bacterial infections. This is especially important during the recovery process when maintaining eyelid hygiene is essential.
Your eye care professional can provide personalized advice and verify that Polysporin is an appropriate choice for your specific situation, consequently optimizing the ointment’s potential benefits while minimizing risks.
Neosporin: Effective Treatment Option
How does Neosporin fit into the treatment landscape for chalazia? As a topical antibiotic ointment, Neosporin contains bacitracin, neomycin, and polymyxin B, which can help prevent secondary bacterial infections in actively draining chalazia.
While chalazia are typically sterile and don’t require antibiotics, using Neosporin can offer symptomatic relief and reduce infection risks when combined with other management strategies. It’s particularly useful if you also have blepharitis or irritation accompanying the chalazion.
Regular eyelid cleansing, as recommended in TheraLife’s approach, is vital for maintaining hygiene and can complement the use of Neosporin.
Applying Neosporin sparingly is important to avoid direct contact with the eye, as neomycin may cause irritation or contact dermatitis in some individuals. Incorporating warm compresses into your routine can enhance the efficacy of Neosporin, promoting drainage and reducing inflammation.
This combination serves as a thorough management strategy, but it’s not without potential complications.
Before you consider Neosporin for your chalazia, consulting with an ophthalmologist is essential. They can confirm whether Neosporin is appropriate for your condition and guide you on its use to prevent complications.
While Neosporin isn’t a frontline treatment for chalazia, it can be an effective adjunct in managing complex cases with infection risks.
Frequently Asked Questions
What Antibiotic Ointment Is Good for Chalazion?
You might wonder about using antibiotic ointments for chalazion, but they aren’t typically effective since chalazion causes aren’t bacterial.
Instead, focus on eye hygiene and topical treatments like warm compresses to reduce inflammation and provide symptom relief. Antibiotics are more for secondary infections.
Natural remedies and consistent care can help with recurrence prevention and improve healing time.
Always seek an ophthalmologist’s advice for precise management tailored to your needs.
What Is the Best Product for a Chalazion?
Think of a chalazion as a clogged drain in your eyelid.
It’s caused by blocked oil glands, not infection. You’ll notice symptoms like swelling and discomfort.
For home remedies, try warm compresses to ease the blockage.
Prevention tips include good eyelid hygiene.
If it persists, consult a professional for treatment options, possibly a surgical procedure.
Recovery time varies, but lifestyle changes can help.
What Is the Best Antibiotic Eye Ointment for Stye?
For treating styes, bacitracin or erythromycin ointments are effective against stye symptoms.
While antibiotics help with infection, don’t forget that proper eye hygiene is essential. Use warm compresses daily to alleviate discomfort and prevent recurrence.
Understand the difference: a stye is an infected eyelash follicle, while a chalazion is a blocked oil gland.
If over-the-counter treatments fail or complications arise, see a doctor.
Consider natural remedies, but prioritize evidence-based options.
Is Eye Ointment Good for Chalazion?
You might wonder if eye ointment is good for chalazion symptoms. While not typically necessary, it can aid swelling reduction if a secondary infection occurs.
Prioritize warm compresses and eyelid hygiene as primary treatment options for effective inflammation relief. Consult a medical professional for personalized eye care advice.
Consider preventive measures and alternative remedies to manage chalazia. Remember, expert guidance guarantees precise treatment and ideal outcomes.
Add To Cart
Conclusion
In treating chalazions, TheraLife’s natural approach offers an effective alternative to traditional antibiotic ointments. Their products, designed with natural ingredients, help promote eye health by reducing inflammation and discomfort associated with chalazions. TheraLife’s solutions are particularly suited for those looking to avoid antibiotics while still seeking relief from persistent eye conditions. Their evidence-based approach ensures safety and efficacy, making them a reliable choice for eye care. For optimal results, consult your healthcare provider for personalized guidance and discover how TheraLife’s offerings can benefit your eye health.
References
- 1.
- Jin KW, Shin YJ, Hyon JY. Effects of chalazia on corneal astigmatism : Large-sized chalazia in middle upper eyelids compress the cornea and induce the corneal astigmatism. BMC Ophthalmol. 2017 Mar 31;17(1):36. [PMC free article] [PubMed]
- 2.
- Fukuoka S, Arita R, Shirakawa R, Morishige N. Changes in meibomian gland morphology and ocular higher-order aberrations in eyes with chalazion. Clin Ophthalmol. 2017;11:1031-1038. [PMC free article] [PubMed]
- 3.
- Mittal R, Tripathy D, Sharma S, Balne PK. Tuberculosis of eyelid presenting as a chalazion. Ophthalmology. 2013 May;120(5):1103.e1-4. [PubMed]
- 4.
- Hanafi Y, Oubaaz A. [Leishmaniasis of the eyelid masquerading as a chalazion: Case report]. J Fr Ophtalmol. 2018 Jan;41(1):e31-e33. [PubMed]
- 5.
- Wu AY, Gervasio KA, Gergoudis KN, Wei C, Oestreicher JH, Harvey JT. Conservative therapy for chalazia: is it really effective? Acta Ophthalmol. 2018 Jun;96(4):e503-e509. [PMC free article] [PubMed]
- 6.
- Chang M, Park J, Kyung SE. Extratarsal presentation of chalazion. Int Ophthalmol. 2017 Dec;37(6):1365-1367. [PubMed]
- 7.
- Carlisle RT, Digiovanni J. Differential Diagnosis of the Swollen Red Eyelid. Am Fam Physician. 2015 Jul 15;92(2):106-12. [PubMed]
- 8.
- Ozer PA, Gurkan A, Kurtul BE, Kabatas EU, Beken S. Comparative Clinical Outcomes of Pediatric Patients Presenting With Eyelid Nodules of Idiopathic Facial Aseptic Granuloma, Hordeola, and Chalazia. J Pediatr Ophthalmol Strabismus. 2016 Jul 01;53(4):206-11. [PubMed]
- 9.
- Aycinena AR, Achiron A, Paul M, Burgansky-Eliash Z. Incision and Curettage Versus Steroid Injection for the Treatment of Chalazia: A Meta-Analysis. Ophthalmic Plast Reconstr Surg. 2016 May-Jun;32(3):220-4. [PubMed]
- 10.
- Park YM, Lee JS. The effects of chalazion excision on corneal surface aberrations. Cont Lens Anterior Eye. 2014 Oct;37(5):342-5. [PubMed]
- 11.
- 12.
- Görsch I, Loth C, Haritoglou C. [Chalazion – diagnosis and therapy]. MMW Fortschr Med. 2016 Jun 23;158(12):52-5. [PubMed]
- Unal M. Chalazion treatment. Orbit. 2008;27(open in a new window)(6(open in a new window)):397–398. doi:10.1080/01676830802623174.
- Shields JA, Shields CL. Atlas of eyelid and conjunctival tumors. Lippincott Raven; 1999.
- Jordan GA, Beier K. Chalazion. StatPearls [Internet]. StatPearls Publishing; 2020.
- Caravaca A, Alió Del Barrio JL, Martínez Hergueta MC, Amesty MA. Intense pulsed light combined with meibomian gland expression for chalazion management. Arch Soc Esp Oftalmol (Engl Ed). 2022;97(open in a new window)(9(open in a new window)):490–496. doi:10.1016/j.oftal.2022.03.005.
- Nemet AY, Vinker S, Kaiserman I. Associated morbidity of blepharitis. Ophthalmology. 2011;118(open in a new window)(6(open in a new window)):1062–1068. doi:10.1016/j.ophtha.2010.10.015.
- Woo YR, Cho M, Ju HJ, Bae JM, Cho SH, Lee JD, Kim HS. Ocular comorbidities in Rosacea: a case–control study based on seven institutions. J Clin Med. 2021;10(open in a new window)(13(open in a new window)):2897. doi: 10.3390/jcm10132897.
- Liang L, Ding X, Tseng SC. High prevalence of Demodex brevis infestation in chalazia. Am J Ophthalmol. 2014;157(open in a new window)(2(open in a new window)):342–348.e1. doi:10.1016/j.ajo.2013.09.031.
- Chen L, Chen X, Xiang Q, Zheng Y, Pi L, Liu Q, Xiao J, Ke N, Fang J. Prevalence of low serum vitamin A levels in young children with chalazia in Southwest China. Am J Ophthalmol. 2014;157(open in a new window)(5(open in a new window)):1103–1108.e2. doi:10.1016/j.ajo.2014.02.020.
- Filippelli M, dell’Omo R, Amoruso A, Paiano I, Pane M, Napolitano P, Campagna G, Bartollino S, Costagliola C. Effectiveness of oral probiotics supplementation in the treatment of adult small chalazion. Int J Ophthalmol. 2022;15(open in a new window)(1(open in a new window)):40–44. doi:10.18240/ijo.2022.01.06.
- Patel S, Tohme N, Gorrin E, Kumar N, Goldhagen B, Galor A. Prevalence and risk factors for chalazion in an older veteran population. Br J Ophthalmol. 2022;106(open in a new window)(9(open in a new window)):1200–1205. doi:10.1136/bjophthalmol-2020-318420.
- Paravathaneni M, Thota V, Mulla S, Thirumaran R, Thar YY. A case report on bortezomib-induced bilateral chalazion. Cureus. 2020;12(open in a new window)(8(open in a new window)):e10062. doi:10.7759/cureus.10062.
- Fraunfelder FW, Yang HK. Association between bortezomib therapy and eyelid chalazia. JAMA Ophthalmol. 2016;134(open in a new window)(1(open in a new window)):88–90. doi:10.1001/jamaophthalmol.2015.3963.
- Goldberg RA, Shorr N. Vertical slat chalazion excision. Ophthalmic Surg. 1992;23(2):120–122.
- Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, others, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(open in a new window)(3(open in a new window)):438–510. doi:10.1016/j.jtos.2017.05.011.
- Robin JB, Jester JV, Nobe J, Nicolaides N, Smith RE. In vivo transillumination biomicroscopy and photography of meibomian gland dysfunction. A clinical study. Ophthalmology. 1985;92(open in a new window)(10(open in a new window)):1423–1426. doi:10.1016/s0161-6420(85)33848-4.
- Filippelli M, dell’Omo R, Amoruso A, Paiano I, Pane M, Napolitano P, Bartollino S, Costagliola C. Intestinal microbiome: a new target for chalaziosis treatment in children? Eur J Pediatr. 2021;180(open in a new window)(4(open in a new window)):1293–1298. doi:10.1007/s00431-020-03880-5.
- Arbabi EM, Kelly RJ, Carrim ZI. Chalazion. BMJ. 2010;341(open in a new window)(Aug04 1(open in a new window)):c4044–c4044. doi:10.1136/bmj.c4044.
- Jin KW, Shin YJ, Hyon JY. Effects of chalazia on corneal astigmatism: large-sized chalazia in middle upper eyelids compress the cornea and induce the corneal astigmatism. BMC Ophthalmol. 2017;17(open in a new window)(1(open in a new window)):36. doi:10.1186/s12886-017-0426-2.
- Bagheri A, Hasani HR, Karimian F, Abrishami M, Yazdani S. Effect of chalazion excision on refractive error and corneal topography. Eur J Ophthalmol. 2009;19(open in a new window)(4(open in a new window)):521–526. doi:10.1177/112067210901900401.
- Yen KG, Chilakapati MC, Coats DK, Miller AM, Paysse EA, Steinkuller PG. Chapter 68 – Ocular infectious diseases. In Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds). Feigin and Cherry’s Textbook of Pediatric Infectious Diseases (Sixth Edition). Philadelphia: W.B. Saunders; 2009. pp. 811–835.
- Bragg KJ, Le PH, Le JK. Hordeolum. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
- Lindsley K, Nichols JJ, Dickersin K. Interventions for acute internal hordeolum. Cochrane Database Syst Rev. 2013;4(4):Cd007742.
- Willmann D, Guier CP, Patel BC, Melanson SW. Stye. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
- McGinley TC Jr. Adult eye conditions: common eye conditions. FP Essent. 2022;519:11–18.
- Zhu D, Gupta RR, Stein RL, Quintero J, Morcos MM, Link TJ, Perry HD. Randomized prospective evaluation of microblepharoexfoliation BlephEx as adjunctive therapy in the treatment of chalazia. Cornea. 2023;42(open in a new window)(2(open in a new window)):172–175. doi:10.1097/ICO.0000000000003090.
- Black RL, Terry JE. Treatment of chalazia with intralesional triamcinolone injection. J Am Optom Assoc. 1990;61(12):904–906.
- Singhania R, Sharma N, Vashisht S, Dewan T. Intralesional triamcinolone acetonide (TA) versus incision and curettage (I&C) for medium and large size chalazia. Nepal J Ophthalmol. 2018;10(open in a new window)(19(open in a new window)):3–10. doi:10.3126/nepjoph.v10i1.21661.
- Wu AY, Gervasio KA, Gergoudis KN, Wei C, Oestreicher JH, Harvey JT. Conservative therapy for chalazia: is it really effective? Acta Ophthalmol. 2018;96(4):e503–e509.
- Shen YC, Wang CY, Tsai HY, Lee YF. Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis. Cornea. 2007;26(open in a new window)(4(open in a new window)):423–426. doi:10.1097/ICO.0b013e318030d230.
- Khurana AK, Ahluwalia BK, Rajan C. Chalazion therapy. Intralesional steroids versus incision and curettage. Acta Ophthalmol (Copenh)). 1988;66(open in a new window)(3(open in a new window)):352–354. doi:10.1111/j.1755-3768.1988.tb04609.x.
- Goawalla A, Lee V. A prospective randomized treatment study comparing three treatment options for chalazia: triamcinolone acetonide injections, incision and curettage and treatment with hot compresses. Clin Exp Ophthalmol. 2007;35(open in a new window)(8(open in a new window)):706–712. doi:10.1111/j.1442-9071.2007.01617.x.
- Shiramizu KM, Kreiger AE, McCannel CA. Severe visual loss caused by ocular perforation during chalazion removal. Am J Ophthalmol. 2004;137(open in a new window)(1(open in a new window)):204–205. doi:10.1016/s0002-9394(03)00863-8.
- Yağci A, Palamar M, Eğrilmez S, Sahbazov C, Ozbek SS. Anterior segment ischemia and retinochoroidal vascular occlusion after intralesional steroid injection. Ophthalmic Plast Reconstr Surg. 2008;24(open in a new window)(1(open in a new window)):55–57. doi:10.1097/IOP.0b013e31815c938f.
- Biuk D, Matić S, Barać J, Vuković MJ, Biuk E, Matić M. Chalazion management–surgical treatment versus triamcinolon application. Coll Antropol. 2013;37 Suppl 1:247–250.
- Korn EL. Laser chalazion removal. Ophthalmic Surg Lasers Imaging. 1988;19(open in a new window)(6(open in a new window)):428–431. doi:10.3928/1542-8877-19880601-11.
- Leachman JW, Boynton JR, Levin DB. Chalazion management by tarsus trephination. Ophthalmic Surg. 1978;9(1):89–90.
- Knezevic T, Ivekovic R, Astalos JP, Novak Laus K, Mandic Z, Matejcic A. Botulinum toxin A injection for primary and recurrent chalazia. Graefes Arch Clin Exp Ophthalmol. 2009;247(open in a new window)(6(open in a new window)):789–794. doi:10.1007/s00417-008-0992-3.
- Fal’bush OA. [The treatment of chalazion by cryogenic action]. Oftalmol Zh. 1989;(6):360–361.
- Worst JG. A new ultra-sharp loop for chalazion and cyst removal-based on the superblade principle. Ophthalmic Surg. 1980;11(2):115.
- Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366(open in a new window):l4898. doi:10.1136/bmj.l4898.
- Kalyana Chakravarthy S, Jayasudha R, Sai Prashanthi G, Ali MH, Sharma S, Tyagi M, Shivaji S. Dysbiosis in the gut bacterial microbiome of patients with uveitis, an inflammatory disease of the eye. Indian J Microbiol. 2018;58(open in a new window)(4(open in a new window)):457–469. doi:10.1007/s12088-018-0746-9.
- Iovieno A, Lambiase A, Sacchetti M, Stampachiacchiere B, Micera A, Bonini S. Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol. 2008;246(open in a new window)(3(open in a new window)):435–441. doi:10.1007/s00417-007-0682-6.
- Tavakoli A, Flanagan JL. The case for a more holistic approach to dry eye disease: is it time to move beyond antibiotics? Antibiotics (Basel). 2019;8(open in a new window)(3(open in a new window)):88. doi:10.3390/antibiotics8030088.
- Lin P. The role of the intestinal microbiome in ocular inflammatory disease. Curr Opin Ophthalmol. 2018;29(open in a new window)(3(open in a new window)):261–266. doi:10.1097/ICU.0000000000000465.
- Baim AD, Movahedan A, Farooq AV, Skondra D. The microbiome and ophthalmic disease. Exp Biol Med (Maywood)). 2019;244(open in a new window)(6(open in a new window)):419–429. doi:10.1177/1535370218813616.
- Perra MT, Serra A, Sirigu P, Turno F. Histochemical demonstration of acetylcholinesterase activity in human Meibomian glands. Eur J Histochem. 1996;40(1):39–44.
- Chung CF, Lai JS, Li PS. Subcutaneous extralesional triamcinolone acetonide injection versus conservative management in the treatment of chalazion. Hong Kong Med J. 2006;12(4):278–281.
- Ben Simon GJ, Rosen N, Rosner M, Spierer A. Intralesional triamcinolone acetonide injection versus incision and curettage for primary chalazia: a prospective, randomized study. Am J Ophthalmol. 2011;151(open in a new window)(4(open in a new window)):714–718.e1. doi:10.1016/j.ajo.2010.10.026.
- Watson AP, Austin DJ. Treatment of chalazions with injection of a steroid suspension. Br J Ophthalmol. 1984;68(open in a new window)(11(open in a new window)):833–835. doi:10.1136/bjo.68.11.833.
- Mustafa TA, Oriafage IH. Three methods of treatment of chalazia in children. Saudi Med J. 2001;22(11):968–972.
- Qurban Q, Kamil Z, Mahmood K. Added advantage of injecting subtarsal steroid injection after incision and curettage of multiple chalazion. J Ayub Med Coll Abbottabad. 2021;33(3):437–440.
- Costa AXD, Gomes JÁP, Marculino LGC, Liendo VL, Barreiro TP, Santos MSD. Supratarsal injection of triamcinolone for severe vernal keratoconjunctivitis in children. Arq Bras Oftalmol. 2017;80(3):186–188.
- Cohen BZ, Tripathi RC. Eyelid depigmentation after intralesional injection of a fluorinated corticosteroid for chalazion. Am J Ophthalmol. 1979;88(open in a new window)(2(open in a new window)):269–270. doi:10.1016/0002-9394(79)90481-1.
- Destafeno JJ, Kodsi SR, Primack JD. Recurrent Staphylococcus aureus chalazia in hyperimmunoglobulinemia E (Job’s) syndrome. Am J Ophthalmol. 2004;138(open in a new window)(6(open in a new window)):1057–1058. doi:10.1016/j.ajo.2004.06.034.
- Koch CH, Fabre L, Montard R, Garcin T, Delbosc B, Gauthier AS. [Inadvertent descemetorhexis as a complication of chalazion surgery]. J Fr Ophtalmol. 2021;44(open in a new window)(4(open in a new window)):e215–e217. doi:10.1016/j.jfo.2020.06.025.
- Milia M, Lefatzis N, Papakosta V, Theodossiadis P, Papathanassiou M. Unusual case of orbital apex syndrome after chalazion excision. Clin Exp Optom. 2013;96(open in a new window)(3(open in a new window)):346–348. doi:10.1111/j.1444-0938.2012.00798.x.
- Son JH, Choi JH, Lim SH. Hypertrophic scar of the conjunctiva presenting as an eyelid mass: an unusual complication after surgical treatment of a chalazion. Springerplus. 2016;5(open in a new window)(1(open in a new window)):1689. doi:10.1186/s40064-016-3368-x.
- Rosignoli L, Potter SM, Gonzalez A, Amin S, Khurshid SG. Development of central serous chorioretinopathy following chalazion removal with intralesional triamcinolone injection: a case report. Case Rep Ophthalmol. 2018;9(open in a new window)(3(open in a new window)):416–420. doi:10.1159/000492714.
- Asensio-Sánchez VM, Pareja-Aricó L, Valentín-Bravo J. Bilateral and multifocal central serous chorioretinopathy after injecting triamcinolone into a chalazion. Arch Soc Esp Oftalmol (Engl Ed.)). 2020;95(open in a new window)(3(open in a new window)):141–145. doi:10.1016/j.oftal.2019.12.007.
- Park J, Chang M. Eyelid fat atrophy and depigmentation after an intralesional injection of triamcinolone acetonide to treat chalazion. J Craniofac Surg. 2017;28(open in a new window)(3(open in a new window)):e198–e199. doi:10.1097/SCS.0000000000003367.
- Procope JA, Kidwell ED Jr. Delayed postoperative hemorrhage complicating chalazion surgery. J Natl Med Assoc. 1994;86(11):865–866.
- Ho SY, Lai JS. Subcutaneous steroid injection as treatment for chalazion: prospective case series. Hong Kong Med J. 2002;8(1):18–20.
- Li J, Li D, Zhou N, Qi M, Luo Y, Wang Y. Effects of chalazion and its treatments on the meibomian glands: a nonrandomized, prospective observation clinical study. BMC Ophthalmol. 2020;20(open in a new window)(1(open in a new window)):278. doi:10.1186/s12886-020-01557-z.
